Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 283
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101...
Red Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic...
PT235 – The Entheo Society of Washington – Dismantling Power Systems...
Pharmadrug Initiates DMT Research Activities via Collaboration with the University of...
Mydecine Innovations Group Provides Update on European Operations
Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35...
DC’s Initiative 81 Becomes Law: Effectively Decriminalizes Entheogenic Plants and Fungi
Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50%...
IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX...
Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its...
Load more